Walgreens Boots Non-GAAP EPS of $0.80 beats by $0.03, revenue of $32.45B beats by $280M
Walgreens Boots press release  (NASDAQ:WBA): FQ4  Non-GAAP EPS of $0.80  beats by $0.03.
Revenue of $32.45B (-5.3% Y/Y)  beats by $280M.

FY2023 Outlook: Adjusted EPS of $4.45 to $4.65 as strong core business growth is more than offset by lapping fiscal year 2022 COVID-19 execution, and currency headwinds vs. consensus of $4.49.
RaisingÂ U.S.Â Healthcare fiscal 2025 sales target to $11B to $12B, with the segment expected to achieve positive adjusted EBITDA by fiscal year 2024.
Increased visibility to the company's long-term growth algorithm, building to low-teens adjusted EPS growth in fiscal year 2025 and beyond.